ExploreIterate

Tara O’Meara

SVP, Clinical Development Operations

Before joining Relay Tx, Tara O’Meara spent nearly a decade at bluebird bio, initially overseeing the development and execution of the clinical program for a rare genetic disease, and most recently, leading the clinical development operations department where she had strategic oversight across all development portfolio, including severe genetic disease and oncology. Prior to bluebird bio, Tara directed the clinical operations group for Synageva BioPharma, now Alexion Pharmaceuticals, and held multiple roles at the Genzyme Corporation, now Sanofi Genzyme, including global team leader for a clinical development program in Pompe disease. Tara has been responsible for everything from small Phase II trials to very large, global Phase III trials in multiple therapeutic areas.


Tara holds a BS in biology and a certificate in women’s studies from Tufts University. Tara also completed the Emerging Leaders Program at University Massachusetts, Boston in 2010.


Social

Roles at Relay Therapeutics

  • SVP, Clinical Development Operations

    April, 2021 - present


My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at Relay Therapeutics

My pet peeves

My communication style

Org chart

Direct reports

No reports

Teams

No teams